Lv5
855 积分 2021-08-20 加入
Ivarmacitinib Sulfate: First Approval
9天前
已完结
Fatigue assessment and its impact in the quality of life of patients with ankylosing spondylitis
14天前
已完结
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients
14天前
已完结
Work productivity and activity impairment in patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a comparative analysis from the POLNOR-Rheuma cohort
14天前
已完结
Axial Spondyloarthritis: A Review
14天前
已完结
Axial spondyloarthritis
15天前
已完结
Ankylosing spondylitis
15天前
已完结
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
19天前
已完结
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
20天前
已完结
皖公网安备34019202002308
